Clincosm LogoSign in Get a demo

Endometrial Cancer

Showing NaN - NaN of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

Recruiting
  • Breast Cancer
  • +3 more
  • Gilbert, Arizona
  • +76 more
Jan 27, 2023

Triple Negative Breast Cancer, Breast Cancer, Endometrial Cancer Trial in New York, Fairfax, Spokane (XMT-1660)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Orange, California
  • +6 more
Jan 23, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

    Recruiting
    • Ovarian Cancer
    • +68 more
    • Phoenix, Arizona
    • +8 more
    Aug 18, 2022

    Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)

    Active, not recruiting
    • Endometrial Cancer
    • Tucson, Arizona
    • +104 more
    Aug 11, 2022

    Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

    Not yet recruiting
    • Endometrial Cancer
    • +4 more
    • Datopotamab deruxtecan (Dato-DXd)
    • +8 more
    • Los Angeles, California
    • +52 more
    Aug 3, 2022

    NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +12 more
    • Tucson, Arizona
    • +26 more
    Aug 1, 2022

    Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

    Recruiting
    • Endometrial Cancer
    • Anchorage, Alaska
    • +78 more
    Jul 25, 2022

    Endometrial Cancer, Endometrial Cancer Recurrent, Lung Cancer Recurrent Trial in United States (RGX-104, Nivolumab, Ipilimumab)

    Recruiting
    • Endometrial Cancer
    • +5 more
    • Los Angeles, California
    • +13 more
    Jul 21, 2022

    Inherited Cancer Syndrome, Prostate Cancer, Colorectal Cancer Trial in Nashville (Correlative Studies (Survey), Correlative

    Not yet recruiting
    • Inherited Cancer Syndrome
    • +4 more
    • Correlative Studies (Survey)
    • +4 more
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Jul 5, 2022

    HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

    Recruiting
    • HER2-positive
    • +30 more
    • CT-0508
    • Duarte, California
    • +4 more
    Feb 1, 2022

    Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

    Recruiting
    • Advanced Cancer
    • +9 more
    • COM701
    • COM701 with Opdivo (Nivolumab).
    • Los Angeles, California
    • +10 more
    Jan 25, 2022

    Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)

    Completed
    • Breast Cancer
    • +3 more
    • FPA150
    • Pembrolizumab
    • Scottsdale, Arizona
    • +17 more
    Jan 6, 2022

    Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

    Recruiting
    • Ovarian Cancer
    • +6 more
    • Tucson, Arizona
    • +25 more
    Dec 20, 2021

    Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

    Completed
    Has Results
    • Gastric Adenocarcinoma
    • +15 more
    • Sacituzumab Govitecan-hziy (SG)
    • Aurora, Colorado
    • +11 more
    Aug 10, 2021

    Endometrial Cancer Trial in Norway, United States (drug, procedure, radiation)

    Completed
    • Endometrial Cancer
    • Los Angeles, California
    • +28 more
    Oct 21, 2020

    Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer Trial in United States (STM 434, Liposomal doxorubicin)

    Completed
    • Ovarian Cancer
    • +3 more
    • STM 434
    • Liposomal doxorubicin
    • Boston, Massachusetts
    • +3 more
    Feb 10, 2017

    Solid Tumor, Colorectal Cancer, Endometrial Cancer Trial in Detroit, New York, Nashville (DS-7423)

    Completed
    • Solid Tumor
    • +2 more
    • Detroit, Michigan
    • +2 more
    Feb 24, 2014

    Endometrial Cancer Trial in Worldwide (docetaxel)

    Completed
    • Endometrial Cancer
    • Birmingham, Alabama
    • +74 more
    Jan 10, 2014

    Endometrial Cancer Trial in Canada, United States (filgrastim, cisplatin, doxorubicin HCl)

    Completed
    • Endometrial Cancer
    • filgrastim
    • +3 more
    • Birmingham, Alabama
    • +72 more
    Jul 8, 2013

    Endometrial Cancer Trial in Worldwide (alvocidib)

    Completed
    • Endometrial Cancer
    • Birmingham, Alabama
    • +53 more
    Jun 20, 2013